Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Verstuyf

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Bone|June 24, 2000
Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1E Daci, A Verstuyf, K Moermans, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1996
Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specificJ Zhao, B K Tan, S Marcelis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1997
Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-beta2 and their combinationsL Verlinden, A Verstuyf, C Mathieu, et al.
British Journal of Pharmacology|May 8, 2013
Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirusV González-Pardo, A Verstuyf, R Boland, et al.
Hormone Research|January 1, 1996
Nonhypercalcemic vitamin D analogs: interactions with the vitamin D-binding proteinR Bouillon, A Verstuyf, J Zhao, et al.
Current Opinion in Nephrology and Hypertension|August 5, 1998
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis)A Verstuyf, C Mathieu, L Verlinden, et al.
International Journal of Cancer|April 15, 1990
Establishment and characterization of a continuous in vitro line from a rat choriocarcinomaA Verstuyf, H Sobis, J Goebels, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogsA Verstuyf, L Verlinden, S Segaert, et al.
Molecular and Cellular Endocrinology|October 23, 1998
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cellsL Verlinden, A Verstuyf, R Convents, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Bone|June 24, 2000
Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1E Daci, A Verstuyf, K Moermans, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1996
Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specificJ Zhao, B K Tan, S Marcelis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1997
Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-beta2 and their combinationsL Verlinden, A Verstuyf, C Mathieu, et al.
British Journal of Pharmacology|May 8, 2013
Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirusV González-Pardo, A Verstuyf, R Boland, et al.
Hormone Research|January 1, 1996
Nonhypercalcemic vitamin D analogs: interactions with the vitamin D-binding proteinR Bouillon, A Verstuyf, J Zhao, et al.
Current Opinion in Nephrology and Hypertension|August 5, 1998
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis)A Verstuyf, C Mathieu, L Verlinden, et al.
International Journal of Cancer|April 15, 1990
Establishment and characterization of a continuous in vitro line from a rat choriocarcinomaA Verstuyf, H Sobis, J Goebels, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogsA Verstuyf, L Verlinden, S Segaert, et al.
Molecular and Cellular Endocrinology|October 23, 1998
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cellsL Verlinden, A Verstuyf, R Convents, et al.
Pageof 5